UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Identification of novel biomarkers for Parkinson's disease by metabolomic technologies

Journal of neurology, neurosurgery and psychiatry, 2016-03, Vol.87 (3), p.295-301

2016

Link zum Volltext

Verfügbarkeit prüfen

Comorbid alpha synucleinopathies in idiopathic normal pressure hydrocephalus

Journal of neurology, 2022-04, Vol.269 (4), p.2022-2029

2022

Link zum Volltext

Verfügbarkeit prüfen

Gray Matter Abnormalities in Idiopathic Parkinson's Disease: Evaluation by Diffusional Kurtosis Imaging and Neurite Orientation Dispersion and Density Imaging

Human brain mapping, 2017-07, Vol.38 (7), p.3704-3722

2017

Link zum Volltext

Verfügbarkeit prüfen

Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease

Movement disorders, 2018-09, Vol.33 (9), p.1488-1492

2018

Link zum Volltext

Verfügbarkeit prüfen

Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease

Scientific reports, 2017-08, Vol.7 (1), p.7328-15, Article 7328

2017

Link zum Volltext

Verfügbarkeit prüfen

Neurite orientation dispersion and density imaging in the substantia nigra in idiopathic Parkinson disease

European radiology, 2016-08, Vol.26 (8), p.2567-2577

2016

Link zum Volltext

Verfügbarkeit prüfen

Preserved proteinase K-resistant core after amplification of alpha-synuclein aggregates: Implication to disease-related structural study

Biochemical and biophysical research communications, 2020-02, Vol.522 (3), p.655-661

2020

Link zum Volltext

Verfügbarkeit prüfen

Variants in saposin D domain of prosaposin gene linked to Parkinson's disease

Brain (London, England : 1878), 2020-04, Vol.143 (4), p.1190-1205

2020

Link zum Volltext

Verfügbarkeit prüfen

Generation of hiPSCs (JUCGRMi003-A) from a patient with Parkinson’s disease with PARK2 mutation

Stem cell research, 2024-04, Vol.76, p.103323-103323, Article 103323

2024

Link zum Volltext

Verfügbarkeit prüfen

Neurite orientation dispersion and density imaging of the nigrostriatal pathway in Parkinson's disease: Retrograde degeneration observed by tract-profile analysis

Parkinsonism & related disorders, 2018-06, Vol.51, p.55-60

2018

Link zum Volltext

Verfügbarkeit prüfen

Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease

Stem cell reports, 2020-06, Vol.14 (6), p.1060-1075

2020

Link zum Volltext

Verfügbarkeit prüfen

Neuromelanin MRI is useful for monitoring motor complications in Parkinson’s and PARK2 disease

Journal of Neural Transmission, 2017-04, Vol.124 (4), p.407-415

2017

Link zum Volltext

Verfügbarkeit prüfen

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy

PloS one, 2019-09, Vol.14 (9), p.e0223113-e0223113

2019

Link zum Volltext

Verfügbarkeit prüfen

Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment

Acta neuropathologica communications, 2018-09, Vol.6 (1), p.96-15, Article 96

2018

Link zum Volltext

Verfügbarkeit prüfen

Shared Metabolic Profile of Caffeine in Parkinsonian Disorders

Movement disorders, 2020-08, Vol.35 (8), p.1438-1447

2020

Link zum Volltext

Verfügbarkeit prüfen

Quantum-dot-labeled synuclein seed assay identifies drugs modulating the experimental prion-like transmission

Communications biology, 2022-06, Vol.5 (1), p.636-636, Article 636

2022

Link zum Volltext

Verfügbarkeit prüfen

Ophthalmic nerve hypertrophy in chronic inflammatory demyelinating polyradiculoneuropathy

Neurology, 2014-04, Vol.82 (17), p.1566

2014

Link zum Volltext

Verfügbarkeit prüfen

Metabolomics‐based identification of metabolic alterations in PARK2

Annals of clinical and translational neurology, 2019-03, Vol.6 (3), p.525-536

2019

Link zum Volltext

Verfügbarkeit prüfen

A Patient with the GLA p.E66Q Mutation Exhibiting Vascular Parkinsonism and Bilateral Pulvinar Lesions

Internal Medicine, 2015, Vol.54(19), pp.2503-2506

2015

Link zum Volltext

Verfügbarkeit prüfen

Cerebral Small Artery Diseases may be Associated with Aortic Arch Calcification in Stroke Patients

Journal of Atherosclerosis and Thrombosis, 2014/10/24, Vol.21(10), pp.1011-1021

2014

Link zum Volltext

Verfügbarkeit prüfen

Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease

Annals of clinical and translational neurology, 2020-03, Vol.7 (3), p.307-317

2020

Link zum Volltext

Verfügbarkeit prüfen

Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease

Journal of Parkinson's disease, 2021-01, Vol.11 (3), p.1221

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of low-density lipoprotein to high-density lipoprotein ratio on aortic arch atherosclerosis in unexplained stroke

Journal of the neurological sciences, 2013-03, Vol.326 (1), p.83-88

2013

Link zum Volltext

Verfügbarkeit prüfen

Antagonism of metabotropic glutamate receptor type 5 prevents levodopa‐induced dyskinesia development in a male rat model of Parkinson's disease: Electrophysiological evidence

Journal of neuroscience research, 2024-03, Vol.102 (3), p.e25302-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Propagative α-synuclein seeds as serum biomarkers for synucleinopathies

Nature medicine, 2023-06, Vol.29 (6), p.1448-1455

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(33)

Sprache

Englisch
(32)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(27)
Humans
(25)
Neurosciences & Neurology
(18)
Male
(15)
Clinical Neurology
(14)
Neurology
(14)
Female
(13)
Middle Aged
(12)
Movement Disorders
(12)
Parkinson's Disease
(12)
Aged
(10)
Neurosciences
(10)
Neurodegenerative Diseases
(9)
Parkinsons Disease
(9)
Atrophy
(6)
Ubiquitin-Protein Ligases - Genetics
(6)
Animals
(5)
Biomarkers - Blood
(5)
Magnetic Resonance Imaging
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Identification of novel biomarkers for Parkinson's disease by metabolomic technologies

Comorbid alpha synucleinopathies in idiopathic normal pressure hydrocephalus

Gray Matter Abnormalities in Idiopathic Parkinson's Disease: Evaluation by Diffusional Kurtosis Imaging and Neurite Orientation Dispersion and Density Imaging

Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease

Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease

Neurite orientation dispersion and density imaging in the substantia nigra in idiopathic Parkinson disease

Preserved proteinase K-resistant core after amplification of alpha-synuclein aggregates: Implication to disease-related structural study

Variants in saposin D domain of prosaposin gene linked to Parkinson's disease

Generation of hiPSCs (JUCGRMi003-A) from a patient with Parkinson’s disease with PARK2 mutation

Neurite orientation dispersion and density imaging of the nigrostriatal pathway in Parkinson's disease: Retrograde degeneration observed by tract-profile analysis

Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease

Neuromelanin MRI is useful for monitoring motor complications in Parkinson’s and PARK2 disease

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy

Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment

Shared Metabolic Profile of Caffeine in Parkinsonian Disorders

Quantum-dot-labeled synuclein seed assay identifies drugs modulating the experimental prion-like transmission

Ophthalmic nerve hypertrophy in chronic inflammatory demyelinating polyradiculoneuropathy

Metabolomics‐based identification of metabolic alterations in PARK2

A Patient with the GLA p.E66Q Mutation Exhibiting Vascular Parkinsonism and Bilateral Pulvinar Lesions

Cerebral Small Artery Diseases may be Associated with Aortic Arch Calcification in Stroke Patients

Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease

Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease

Impact of low-density lipoprotein to high-density lipoprotein ratio on aortic arch atherosclerosis in unexplained stroke

Antagonism of metabotropic glutamate receptor type 5 prevents levodopa‐induced dyskinesia development in a male rat model of Parkinson's disease: Electrophysiological evidence

Propagative α-synuclein seeds as serum biomarkers for synucleinopathies

Suchergebnisse filtern